Search

everythinglearnresearchcommunity

for

Search:↓

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Trichoscopy is better than the hair pull test for tracking alopecia areata.

The U.K. created the CPSA to set safety standards for non-surgical cosmetic treatments and improve patient protection.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

New treatments for severe alopecia areata show promise but lack standard approval.

Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.

Stem cells show promise for hair loss and skin treatments in aesthetics but need more research on safety and standard methods.

Licorice can effectively treat stomach ulcers and may work as well as or better than some standard drugs.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Some alternative treatments for vitiligo show promise but need more research to confirm their safety and effectiveness.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

Hormonal therapies might help treat hidradenitis suppurativa, but treatment is complex and personalized.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Combining PRP, microneedling, and minoxidil may improve hair regrowth in severe hair loss cases.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

Photodynamic therapy shows promise for oral lichen planus but needs more research for consistent results.

Topical and oral minoxidil are the best treatments for monilethrix.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.